We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
NanoBioNexus Contracted to Head Educational Component at Regional Center of Cancer Nanotechnology Excellence
News

NanoBioNexus Contracted to Head Educational Component at Regional Center of Cancer Nanotechnology Excellence

NanoBioNexus Contracted to Head Educational Component at Regional Center of Cancer Nanotechnology Excellence
News

NanoBioNexus Contracted to Head Educational Component at Regional Center of Cancer Nanotechnology Excellence

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NanoBioNexus Contracted to Head Educational Component at Regional Center of Cancer Nanotechnology Excellence "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

NanoBioNexus, Inc. (NBN), a non-profit organization devoted to nanobiotechnology, has announced that contract terms have been finalized with the University of California, San Diego, the lead member of the recently awarded Centers of Cancer Nanotechnology Excellence (CCNE), to head the educational component of the Center.

The National Cancer Institute (NCI) has made a significant commitment to nanotechnology research for cancer and set aside a total of $144.3 million for the formation of seven CCNE’s nationwide.  NCI awarded the University of California, San Diego $3.9 million for the first year of a five-year $20 million cancer-nanotechnology platform partnership.

Members of the recently funded "Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer" (NanoTUMOR) include the University of California, San Diego, Moores UCSD Cancer Center, the Burnham Institute, NanoBioNexus, and the University of California campuses at Irvine, Riverside and Santa Barbara. 

The charter of the educational component is to provide education and facilitate communication in the community for applications of nanotechnology in oncology. 

William Vine, M.D., Ph.D., of NanoBioNexus is co-principal investigator heading the education core together with renowned oncologist Joanne Mortimer, M.D., professor of Clinical Medicine and deputy director, Clinical Oncology at the Moores Cancer Center. 

Adriana Vela, founder and chair of the seasoned team of scientist and business professionals leading NBN said, "NanoBioNexus is honored to have been invited to participate as a member of the Center and is proud to be part of this holistic goal of applying nanotechnology to eliminate suffering and death due to cancer.  We are eager to contribute to its success."    

Advertisement